DPF1 Activators
Histone deacetylase inhibitors like Trichostatin A, SAHA, Valproic Acid, Mocetinostat, Entinostat, and Panobinostat could modulate the chromatin landscape, enhancing DPF1's ability to regulate gene expression. By altering histone acetylation levels, these compounds might indirectly affect DPF1's interaction with chromatin, thereby influencing its role in transcriptional regulation and possibly neuronal development.
DNA methyltransferase inhibitors such as 5-Azacytidine and RG108, along with histone methyltransferase inhibitors like BIX-01294, EPZ-6438, UNC1999, and the BET bromodomain inhibitor JQ1, target different aspects of the epigenetic machinery. These compounds can alter DNA methylation and histone modification patterns, impacting DPF1's function in epigenetic regulation of gene expression. The alteration of the epigenetic landscape could influence the transcriptional control exerted by DPF1, particularly in processes like development and differentiation where epigenetic regulation is crucial.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor. It can influence chromatin structure and gene expression, potentially affecting DPF1's regulatory roles in transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor. It can alter DNA methylation patterns, potentially affecting the transcriptional regulation activities of DPF1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor. By altering chromatin dynamics, it could impact DPF1's function in gene expression modulation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A non-nucleoside DNA methyltransferase inhibitor, potentially affecting DPF1's role in epigenetic regulation of gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
A histone deacetylase inhibitor, studied in the research of epilepsy. It may influence DPF1's activity in chromatin remodeling and gene expression. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 free base | sc-202651 | 5 mg | $148.00 | 4 | |
A G9a histone methyltransferase inhibitor, potentially influencing DPF1's role in histone methylation and transcription regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
A histone deacetylase inhibitor. It could affect DPF1's function in regulating gene expression through chromatin modification. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
An inhibitor of EZH2, a histone methyltransferase. It could indirectly impact DPF1's role in chromatin-mediated gene regulation. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective inhibitor of EZH2 and EZH1. It might influence DPF1's function in histone methylation and gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A histone deacetylase inhibitor, which could affect DPF1's role in epigenetic regulation and transcriptional control. | ||||||